These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26688042)

  • 21. Pharmaceutical pipeline.
    Lowen T
    Minn Med; 2011 Oct; 94(10):16-8. PubMed ID: 23256279
    [No Abstract]   [Full Text] [Related]  

  • 22. The importance of chemistry for the future of the pharma industry.
    Wild H; Heimbach D; Huwe C
    Angew Chem Int Ed Engl; 2011 Aug; 50(33):7452-3. PubMed ID: 21818828
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug discovery in the next decade: innovation needed ASAP.
    Bennani YL
    Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial watch: personalized medicines in late-stage development.
    Milne CP; Garafalo S; Bryan C; McKiernan M
    Nat Rev Drug Discov; 2014 May; 13(5):324-5. PubMed ID: 24781541
    [No Abstract]   [Full Text] [Related]  

  • 25. Pediatric drug development.
    Walson PD
    Clin Ther; 2014 Feb; 36(2):154-5. PubMed ID: 24529286
    [No Abstract]   [Full Text] [Related]  

  • 26. [Identification of a molecular mechanism for actions of existing medicines and its application for drug development].
    Mizushima T
    Yakugaku Zasshi; 2012; 132(6):713-20. PubMed ID: 22687730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes.
    Turner MJ
    Drug Discov Today; 2015 Aug; 20(8):917-9. PubMed ID: 26100736
    [No Abstract]   [Full Text] [Related]  

  • 28. Opportunities and challenges with microphysiological systems: a pharma end-user perspective.
    Ewart L; Roth A
    Nat Rev Drug Discov; 2021 May; 20(5):327-328. PubMed ID: 33619385
    [No Abstract]   [Full Text] [Related]  

  • 29. Academia and industry: allocating credit for discovery and development of new therapies.
    Flier JS
    J Clin Invest; 2019 May; 129(6):2172-2174. PubMed ID: 31107243
    [No Abstract]   [Full Text] [Related]  

  • 30. The risky business of drug development in neurology.
    Craven R
    Lancet Neurol; 2011 Feb; 10(2):116-7. PubMed ID: 21256451
    [No Abstract]   [Full Text] [Related]  

  • 31. Virtual drug discovery with the rise of Chinese CROs.
    Zhang MQ
    Drug Discov Today; 2010 Sep; 15(17-18):693-7. PubMed ID: 20685343
    [No Abstract]   [Full Text] [Related]  

  • 32. The Osler Lecture 2012: 'pharmacology 2.0, medicines, drugs and human enhancement'.
    Flower R
    QJM; 2012 Sep; 105(9):823-30. PubMed ID: 22723455
    [No Abstract]   [Full Text] [Related]  

  • 33. An audience with...John Reed.
    Reed J; Mullard A
    Nat Rev Drug Discov; 2014 Mar; 13(3):170-1. PubMed ID: 24577393
    [No Abstract]   [Full Text] [Related]  

  • 34. Future directions of imaging MS in pharmaceutical R&D.
    Goodwin RJ; Webborn PJ
    Bioanalysis; 2015; 7(20):2667-73. PubMed ID: 26510897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Innovative Medicines Initiative: an engine for regulatory science.
    Goldman M; Seigneuret N; Eichler HG
    Nat Rev Drug Discov; 2015 Jan; 14(1):1-2. PubMed ID: 25503331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population.
    van Riet-Nales DA; van den Bemt B; van Bodegom D; Cerreta F; Dooley B; Eggenschwyler D; Hirschlérova B; Jansen PAF; Karapinar-Çarkit F; Moran A; Span J; Stegemann S; Sundberg K
    Br J Clin Pharmacol; 2022 Feb; 88(4):1500-1514. PubMed ID: 35141926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reinventing bioinnovation.
    Kaitin KI; Honig PK
    Clin Pharmacol Ther; 2013 Sep; 94(3):279-83. PubMed ID: 23963211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining Manufacturing Readiness for Breakthrough Drug Development.
    Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP
    AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693
    [No Abstract]   [Full Text] [Related]  

  • 39. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 40. 2011 in reflection.
    Mullard A
    Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.